Home › Research › Risk factors
Alzheimer Europe Publication Highlights Inequalities in Access to Dementia Care and Treatment Across Europe
Jean Georges. European Neurological Review, 2017
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
The objective of a new report, ‘European Dementia Monitor 2017: comparing and benchmarking national dementia strategies and policies’, is to provide a benchmark of national dementia policies in order to compare the responses of European countries to the dementia challenge in different domains. This benchmarking of national dementia policies is intended as a tool for national organisations to compare their situation to that of other European countries. For Alzheimer Europe as a European organisation it is key to understand what differences exist, why they exist and how to find better solutions.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Georges, J. (2017). Alzheimer Europe Publication Highlights Inequalities in Access to Dementia Care and Treatment Across Europe. European Neurological Review. https://doi.org/10.17925/enr.2017.12.02.68
Vancouver
Georges J. Alzheimer Europe Publication Highlights Inequalities in Access to Dementia Care and Treatment Across Europe. European Neurological Review. 2017. doi:10.17925/enr.2017.12.02.68.
BibTeX
@article{georges2017-97680966,
author = {Georges, Jean},
title = {{Alzheimer Europe Publication Highlights Inequalities in Access to Dementia Care and Treatment Across Europe}},
journal = {European Neurological Review},
year = {2017},
doi = {10.17925/enr.2017.12.02.68},
url = {https://doi.org/10.17925/enr.2017.12.02.68}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The objective of a new report, ‘European Dementia Monitor 2017: comparing and benchmarking national dementia strategies and policies’, is to provide a benchmark of national dementia policies in order to compare the responses of European countries to the dementia challenge in different domains.
- This benchmarking of national dementia policies is intended as a tool for national organisations to compare their situation to that of other European countries.
- For Alzheimer Europe as a European organisation it is key to understand what differences exist, why they exist and how to find better solutions.
Why it matters
This report benchmarks national dementia policies across Europe to compare countries' responses to the dementia challenge. It is about access to dementia care and treatment, not about curing or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Evidence strengthLow
How this study scored 24/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 23 of the 96 points we could judge it on, which is 24 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (European Neurological Review) |
| Journal's citation record | 0 / 4 | European Neurological Review: journal h-index 17 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2017 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 3 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 11 year(s) since 2017 |
| Impact for its field and year | 1 / 6 | Cited 0.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | 0 / 3 | Alzheimer Europe: institution h-index 52 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 23 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 23 of the 96 points we could judge it on is 24 out of 100. |
| Total | 24 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk factors from nearby years
Also in Risk factors
356 studies in the library are filed under Risk factors with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk factors hub.